• Home
  • Authors Bio
  • The Book
    • The Origin of Disease
  • Excerpt
  • Reviews
  • Gallery
  • Other Works
  • Contact
  • Blog
  • Order Now

28 Dec

Early treatment of covid-19 could reduce disease severity and hospitalizations

Carolyn Merchant Blog 0 0
NM is planning an outpatient facility, for newly diagnosed, symptomatic, covid-19 patients to receive a one-time IV infusion of covid-19 antibodies. The drug companies report an over-supply of covid-19 antibody drugs; that treatment is most effective when administered within 10 days of symptom onset; and that their studies showed patients who received the infusion shortly after diagnosis did not need further medical treatment.
 
Treating newly diagnosed covid-19 patients shortly after diagnosis, rather than waiting to determine which patients develop severe disease based on arrival at the hospital emergency room, seems like a common sense idea. A combination of effective acute care and a vaccine for covid-19 is a way to relieve the burden on hospitals and society, and reduce the fear surrounding covid-19.
 
Early, outpatient antibody treatment will likely reduce hospitalizations, the spread of covid-19, and human suffering; and protect against the risk of long-hauler complications. Further testing of currently available drugs and drug combinations, in newly diagnosed covid-19 patients, is also warranted.

chronic disease
Facebook

About the Author

Written by Carolyn Merchant

https://www.youtube.com/watch?v=WbG6mzYUnyU&feature=youtu.be&fbclid=IwAR07cSRiUzBpr1LyW6_XXDtifWuQI9z0N3RTdP37Hv9HXv6oyu1qvRAe1gg


Leave a Reply Cancel reply

Your email address will not be published.

Recent Posts

  • Covid19 can lead to more severe outcomes in patients with mental illness
  • Mental illness requires medical diagnosis before a psychiatric diagnosis
  • Medical research requires collaboration to find the causes of chronic disease
  • Inflammation is a response to an infection–not an independent disease
  • The scientific method and specialization are limiting discovery

Recent Comments

  • sjrtawwyxi on Mental health among veterans
  • Man Flink on Chlamydia psittacosis transmission
  • Elvera Syer on Lymphoma and psittacosis
  • Noe Ballerini on Chlamydia psittacosis transmission
  • Eleanora Escher on Lymphoma and psittacosis

Archives

  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018

Categories

  • Blog

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Tags

Abnormal proteins Alzheimer's Alzheimer's disease Animals antibiotics arthritis autism autoimmune Cancer cardiovascular disease Chlamydia chronic disease chronic infection diabetes diagnosis eye disease Eyes gastrointestinal gastrointestinal disease Genetic disease H-pylori H-pylori family Heart disease Inflammation Influenza Medical history Medical research Mental health mental illness microbiology multiple sclerosis neurologic disease Parasites parkinson's psittacosis reproductive reproductive disease Specialization Theory of disease toxoplasmosis trachoma treatment viruses vision zika virus


  • Home
  • Authors Bio
  • The Book
  • Excerpt
  • Reviews
  • Gallery
  • Other Works
  • Contact
  • Blog
  • Order Now

Copyright © 2018. Carolyn Merchant, JD & Christopher Merchant, MD. All rights reserved.